GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 2 filers reported holding GW PHARMACEUTICALS PLC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $50,000 | -99.9% | 235 | -56.1% | 0.00% | -100.0% |
| Q4 2020 | $34,650,000 | +18.6% | 535 | 0.0% | 0.10% | +630.8% |
| Q3 2020 | $29,227,000 | -20.7% | 535 | 0.0% | 0.01% | -40.9% |
| Q2 2020 | $36,844,000 | +40.1% | 535 | 0.0% | 0.02% | +22.2% |
| Q1 2020 | $26,291,000 | +62497.6% | 535 | +118.4% | 0.02% | – |
| Q2 2019 | $42,000 | -99.8% | 245 | +4.3% | 0.00% | -100.0% |
| Q4 2018 | $22,886,000 | -41.8% | 235 | 0.0% | 0.01% | -38.5% |
| Q3 2018 | $39,306,000 | +18.8% | 235 | 0.0% | 0.01% | +8.3% |
| Q2 2018 | $33,083,000 | +33.0% | 235 | 0.0% | 0.01% | -14.3% |
| Q1 2018 | $24,877,000 | -19.5% | 235 | 0.0% | 0.01% | -17.6% |
| Q4 2017 | $30,902,000 | -1.1% | 235 | -17.5% | 0.02% | -10.5% |
| Q3 2017 | $31,244,000 | -6.8% | 285 | -14.9% | 0.02% | -13.6% |
| Q2 2017 | $33,533,000 | +0.5% | 335 | +17.5% | 0.02% | +37.5% |
| Q1 2017 | $33,371,000 | +19.3% | 285 | +21.3% | 0.02% | -15.8% |
| Q4 2016 | $27,979,000 | – | 235 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lamond Capital Partners LLC | 134,230 | $9,085,000 | 5.95% |
| VHCP Management, LLC | 311,853 | $21,106,000 | 5.81% |
| Iguana Healthcare Management, LLC | 60,000 | $4,061,000 | 1.96% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 366,187 | $24,784,000 | 0.95% |
| ACUTA CAPITAL PARTNERS, LLC | 20,000 | $1,354,000 | 0.92% |
| United Asset Strategies, Inc. | 14,278 | $966,000 | 0.41% |
| PRUDENTIAL PLC | 823,408 | $55,728,000 | 0.24% |
| Rock Springs Capital Management LP | 28,000 | $1,895,000 | 0.22% |
| CLOUGH CAPITAL PARTNERS L P | 84,600 | $5,726,000 | 0.20% |
| Eventide Asset Management | 25,000 | $1,692,000 | 0.18% |